Acute myelopathy following chimeric antigen receptor (CAR) T cell therapy: an unusual diagnostic challenge - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Acute Myelopathy After CAR T-Cell Therapy: A Rare Diagnostic Dilemma

  • By

  • Antoine Bois

  • Corentin Provost

  • Justine Decroocq

  • Sarah Benghanem

  • October 8, 2026

Share

Original Source(s)

Acute myelopathy following chimeric antigen receptor (CAR) T cell therapy: an unusual diagnostic challenge

  • by Antoine Bois, Corentin Provost, Justine Decroocq, Sarah Benghanem

  • October 8, 2026

Related Content

Bayesian network meta-analysis comparing efficacy of surgical gastrojejunostomy, endoscopic stenting, and EUS-guided gastroenterostomy for malignant gastric outlet obstruction

Final analysis results from DREAMM-3, a phase 3 study of belantamab mafodotin versus pomalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma

Defensive responses to the U.S. Surgeon General’s alcohol-cancer advisory: A topic modeling analysis of TikTok comments